세계의 구조적 심질환용 기기 시장 규모, 점유율, 성장 분석, 제품별, 시술별, 지역별 시장 규모, 점유율, 성장 분석 - 산업 예측(2024-2031년)

Structural Heart Devices Market size was valued at USD 10.97 billion in 2022 and is poised to grow from USD 11.97 billion in 2023 to USD 24.58 billion by 2031, growing at a CAGR of 9.4% in the forecast period (2024-2031)

The global structural heart devices market is experiencing robust growth, fueled by several key factors, including the rising incidence of structural heart diseases, advancements in minimally invasive surgical techniques, and an expanding aging demographic. As the prevalence of cardiovascular conditions escalates, the demand for structural heart devices continues to increase, further driving the adoption of innovative treatment options. The market is bolstered by a strong push for technologically advanced devices and significant investments in research and development, highlighting the importance of innovation in this sector. However, challenges such as the high costs of these devices and strict regulatory hurdles could hinder growth. Despite these obstacles, the market is anticipated to maintain its upward trajectory, supported by continuous advancements in structural heart device technology and a heightened focus on patient-centered care within cardiology. In particular, the U.S. structural heart devices market is well-positioned for sustainable growth, with expectations for a steady compound annual growth rate (CAGR) in the upcoming forecast period. This trend underscores the healthcare industry's commitment to improving patient outcomes through enhanced treatment options and cutting-edge technological solutions in the realm of structural heart diseases.

Top-down and bottom-up approaches were used to estimate and validate the size of the Structural Heart Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Structural Heart Devices Market Segmental Analysis

Global Structural Heart Devices Market is segmented by Product, Procedure, and region. Based on Product, the market is segmented into Heart Valve Devices (Transcatheter Heart Valves, Surgical Heart Valves (Tissue Heart Valves, Mechanical Heart Valves)), Occluders & Delivery Systems, Annuloplasty Rings, Accessories, and Other Devices. Based on Procedure, the market is segmented into Replacement Procedures (TAVR Procedures, Savr Procedures), Repair Procedures (Closure Procedures, Annuloplasty, Valvuloplasty, TMVR Procedures). Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Driver of the Structural Heart Devices Market

The global structural heart devices market is significantly driven by the rising prevalence of structural heart diseases, including heart valve disorders and congenital abnormalities, which necessitate advanced treatment options. As the incidence of these conditions escalates, the demand for specialized devices has surged. Furthermore, technological advancements in minimally invasive procedures have enhanced patient outcomes, making treatments more accessible and effective. Coupled with the increasing geriatric population, which is particularly vulnerable to these ailments, the market continues to expand. This growing demographic shift and innovation in medical devices create a robust environment for the structural heart devices market's growth and evolution.

Restraints in the Structural Heart Devices Market

The global structural heart devices market faces a significant restraint due to the high costs associated with these advanced medical devices and their implantation procedures. The expense encompasses not only the devices themselves but also the comprehensive costs of development, clinical trials, and adherence to regulatory standards, which can place a financial strain on both patients and healthcare systems. In particular, developing regions may experience limited accessibility and affordability, further curtailing market penetration. Additionally, price sensitivity among consumers and restricted insurance coverage in certain markets can impede the widespread adoption of structural heart devices, ultimately stunting the overall growth of the market.

Market Trends of the Structural Heart Devices Market

A prominent trend in the global structural heart devices market is the surge in minimally invasive procedures, exemplified by transcatheter aortic valve replacement (TAVR) and transcatheter mitral valve repair (TMVR). These innovative techniques are increasingly favored for their substantial advantages, including shorter hospital stays, expedited recovery times, and diminished complications compared to conventional open-heart surgeries. This growth is propelled by continuous advancements in medical technology that enhance procedural precision and efficacy. As healthcare providers and patients alike recognize the benefits of these less invasive options, the demand for structural heart devices is expected to rise steadily, shaping the market's future landscape.

Table of Contents

Introduction

• Objectives of the Study
• Definitions
• Market Scope

Research Methodology

• Information Procurement
• Secondary & Primary Data Sources
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Market Overview Outlook
• Supply Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factor
• Degree of Competition
• Top Investment Pockets
• Ecosystem of the Market
• Regulatory Analysis
• Case Study Analysis
• Market Attractiveness Index
• Supply Chain Analysis
• Customer & Buying Criteria Analysis

Structural Heart Devices Market, By Product

• Market Overview
• Heart Valve Devices
  • Transcatheter Heart Valves
  • Surgical Heart Valves
  • Tissue Heart Valves
  • Mechanical Heart Valves
• Occluders & Delivery Systems
• Annuloplasty Rings
• Accessories
• Other Devices

Structural Heart Devices Market, By Procedure

• Replacement Procedures
• Tavr Procedures
• Savr Procedures
• Repair Procedures
• Closure Procedures
• Annuloplasty
• Valvuloplasty
• Tmvr Procedures

Structural Heart Devices Market Size by Region

• Market Overview
• North America
  • USA
  • Canada
• Europe
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Rest of Latin America
• Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA

Competitive Landscape

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Activities in the Market
• Key Companies Market Share (%), 2023

Key Company Profiles

• Boston Scientific Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Edwards Lifesciences Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biomerics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teleflex Incorporated
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LivaNova PLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• JenaValve Technology, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CardioKinetix
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lepu Medical Technology
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CryoLife
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Micro Interventional Devices
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Braile Biomedica
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• TTK Healthcare (A TTK Group Company)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments